Organon & Co. (OGN)
7.18
+0.23
(+3.31%)
USD |
NYSE |
Dec 10, 16:00
7.18
0.00 (0.00%)
After-Hours: 20:00
Organon Market Cap: 1.867B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 242.20B |
| Amgen, Inc. | 169.78B |
| Regeneron Pharmaceuticals, Inc. | 76.34B |
| Rockwell Medical, Inc. | 37.63M |
| United Therapeutics Corp. | 20.87B |
Market Cap Related Metrics
| PE Ratio | 3.732 |
| PS Ratio | 0.2967 |
| Price to Book Value | 2.060 |
| Price to Free Cash Flow | 3.127 |
| Price | 7.18 |
| Earnings Yield | 26.80% |
| Operating PE Ratio | 1.424 |
| Normalized PE Ratio | 3.349 |